Market Overview

Aimmune Therapeutics (NASDAQ: AIMT)

28.28 +1.65 (6.20%)

Analyst Ratings

DateResearch FirmActionCurrentPT
9/14/18Stifel NicolausInitiates Coverage OnHold33.0
8/13/18Credit SuisseMaintainsOutperform40.0
3/05/18Credit SuisseMaintainsOutperform47.0
2/07/18RBC CapitalInitiates Coverage OnOutperform55.0
12/20/17BairdInitiates Coverage OnOutperform64.0
12/13/17Cantor FitzgeraldInitiates Coverage OnOverweight55.0
10/23/17Credit SuisseMaintainsOutperform45.0
3/07/16Credit SuisseMaintainsOutperform35.0
3/01/16WedbushInitiates Coverage onOutperform42.0
1/22/16Credit SuisseMaintainsOutperform44.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter